Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
11.13
-0.11 (-0.98%)
Apr 30, 2025, 3:04 PM CST
SHE:002317 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -267.84 | -299.16 | 263.27 | 322.05 | 277.63 | -426.61 | Upgrade
|
Depreciation & Amortization | 117.9 | 117.9 | 121.15 | 99.57 | 96.02 | 98.67 | Upgrade
|
Other Amortization | 9.45 | 9.45 | 2.55 | 2.09 | 0.82 | 0.2 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.03 | -0.03 | -21.68 | -14.69 | 0.63 | -0.57 | Upgrade
|
Asset Writedown & Restructuring Costs | 500.89 | 500.89 | 30.56 | 2.83 | 2.22 | 861.72 | Upgrade
|
Loss (Gain) From Sale of Investments | -6.65 | -6.65 | 41.7 | -26.85 | 46.06 | -238.28 | Upgrade
|
Provision & Write-off of Bad Debts | 3.21 | 3.21 | -1.25 | 1.79 | - | - | Upgrade
|
Other Operating Activities | 22.19 | 2.68 | 22.6 | 80.6 | 64.79 | 20.27 | Upgrade
|
Change in Accounts Receivable | -348.14 | -348.14 | -710.08 | -427.22 | 254.02 | 255.36 | Upgrade
|
Change in Inventory | 24.19 | 24.19 | -39.65 | -29.94 | -54.91 | -31.23 | Upgrade
|
Change in Accounts Payable | 314.51 | 314.51 | 524.36 | 43.89 | -48.87 | -449.25 | Upgrade
|
Change in Other Net Operating Assets | 15.82 | 15.82 | -25.73 | - | - | - | Upgrade
|
Operating Cash Flow | 388.68 | 337.84 | 190.61 | 63.07 | 622.77 | 138.93 | Upgrade
|
Operating Cash Flow Growth | 51.20% | 77.24% | 202.23% | -89.87% | 348.25% | -44.68% | Upgrade
|
Capital Expenditures | -236.9 | -228.26 | -363.06 | -267.96 | -213.76 | -154.43 | Upgrade
|
Sale of Property, Plant & Equipment | 0.31 | 0.9 | 11.49 | 14.76 | 1.55 | 20.24 | Upgrade
|
Cash Acquisitions | - | - | - | - | - | -40.41 | Upgrade
|
Divestitures | - | - | - | 0.6 | - | 225.54 | Upgrade
|
Investment in Securities | 516.04 | 565.87 | -410.75 | -279.06 | -477.3 | 137.43 | Upgrade
|
Other Investing Activities | 34.54 | 46.16 | 19.08 | 4.94 | 4.69 | 15.42 | Upgrade
|
Investing Cash Flow | 313.99 | 384.67 | -743.24 | -526.73 | -684.83 | 203.78 | Upgrade
|
Long-Term Debt Issued | - | 301.89 | 1,293 | 1,058 | 399.78 | 943.77 | Upgrade
|
Total Debt Issued | 349.79 | 301.89 | 1,293 | 1,058 | 399.78 | 943.77 | Upgrade
|
Long-Term Debt Repaid | - | -725.06 | -1,050 | -583.1 | -608.08 | -659 | Upgrade
|
Total Debt Repaid | -430.23 | -725.06 | -1,050 | -583.1 | -608.08 | -659 | Upgrade
|
Net Debt Issued (Repaid) | -80.44 | -423.17 | 243.2 | 474.89 | -208.3 | 284.77 | Upgrade
|
Issuance of Common Stock | 37.08 | 37.08 | 590.2 | 64.06 | - | - | Upgrade
|
Repurchase of Common Stock | -8.93 | -8.93 | -2.63 | -0.16 | -51.6 | - | Upgrade
|
Common Dividends Paid | -169.67 | -170.95 | -171.53 | -181.42 | -186.83 | -196.02 | Upgrade
|
Other Financing Activities | -442.57 | 3.81 | 182.49 | 0.23 | 202.37 | 70.64 | Upgrade
|
Financing Cash Flow | -664.53 | -562.17 | 841.72 | 357.6 | -244.36 | 159.39 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.02 | 0.02 | 0.4 | 3.16 | -0.83 | 0.4 | Upgrade
|
Net Cash Flow | 38.15 | 160.36 | 289.49 | -102.9 | -307.25 | 502.5 | Upgrade
|
Free Cash Flow | 151.78 | 109.58 | -172.44 | -204.89 | 409 | -15.5 | Upgrade
|
Free Cash Flow Margin | 6.17% | 4.44% | -6.61% | -7.66% | 16.84% | -0.82% | Upgrade
|
Free Cash Flow Per Share | 0.18 | 0.13 | -0.21 | -0.25 | 0.52 | -0.02 | Upgrade
|
Cash Income Tax Paid | 204.86 | 225.72 | 215.77 | 206.73 | 231.56 | 218.8 | Upgrade
|
Levered Free Cash Flow | -28.58 | 598.14 | -12.01 | -237.88 | 186.71 | 221.27 | Upgrade
|
Unlevered Free Cash Flow | -16.16 | 613.98 | 17.31 | -192.03 | 232.85 | 244.52 | Upgrade
|
Change in Net Working Capital | 44.69 | -582.68 | -40.29 | 263.51 | -119.67 | -141.48 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.